Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 18
526
Views
6
CrossRef citations to date
0
Altmetric
Research Articles

Melognine, a novel monoterpenoid indole alkaloid from Melodinus fusiformis that induce apoptosis in BT549 cells

ORCID Icon, , &
Pages 3004-3010 | Received 17 Jul 2019, Accepted 08 Oct 2019, Published online: 01 Nov 2019

References

  • Cai XH, Li Y, Liu YP, Li XN, Bao MF, Luo XD. 2012. Alkaloids from Melodinus yunnanensis. Phytochemstry. 83(1):116–124.
  • DeAngelis LM. 2005. Chemotherapy for brain tumors-a new beginning. N Engl J Med. 352(10):1036–1038.
  • Elmore S. 2007. Apoptosis: a review of programmed cell death. Toxicol Pathol. 35(4):495–516.
  • Fang ZY, Ren YD, Du SY, Zhang M, Wan YS, Fang L, Zhang H. 2019. Melosuavine I, an apoptosis-inducing bisindole alkaloid from Melodinus suaveolens. Fitoterapia. 133(3):175–179.
  • Feng T, Cai XH, Li Y, Wang YY, Liu YP, Xie MJ, Luo XD. 2009. Melohenines A and B, two unprecedented alkaloids from Melodinus henryi. Org Lett. 11(21):4834–4837.
  • Feng T, Li Y, Liu YP, Cai XH, Wang YY, Luo XD. 2010a. Melotenine A, a cytotoxic monoterpenoid indole alkaloid from Melodinus tenuicaudatus. Org Lett. 12(5):968–971.
  • Feng T, Li Y, Wang YY, Cai XH, Liu YP, Luo XD. 2010b. Cytotoxic indole alkaloids from Melodinus tenuicaudatus. J Nat Prod. 73(6):1075–1079.
  • Fulda S. 2015. Targeting extrinsic apoptosis in cancer: challenges and opportunities. Semin Cell Dev Biol. 39:20–25.
  • He X, Zhou Y, Huang ZH. 1992. Study on the alkaloids of Melodinus fusiformis. Acta Chim Sin. 50:96–101.
  • He YL, Chen WM, Feng XZ. 1994. The alkaloids of Melodinus morsei. Phytochemstry. 37(4):1055–1057.
  • Jiang JH, Zhang WD, Chen YG. 2016. Phytochemical and pharmacological properties of the genus Melodinus. Trop J Pharm Res. 14(12):2325–2344.
  • Kinloch RA, Treherne JM, Furness LM, Hajimohamadreza I. 1999. The pharmacology of apoptosis. Trends Pharmacol Sci. 20(1):35–42.
  • Liu YP, Li Y, Cai XH, Li XY, Kong LM, Cheng GG, Luo XD. 2012. Melodinines M-U, cytotoxic alkaloids from Melodinus suaveolens. J Nat Prod. 75(2):220–224.
  • Liu YP, Zhao YL, Feng T, Cheng GG, Zhang BH, Li Y, Cai XH, Luo XD. 2013. Melosuavines A-H, cytotoxic bisindole alkaloid derivatives from Melodinus suaveolens. J Nat Prod. 76(12):2322–2329.
  • Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A. 2016. Cancer treatment and survivorship statistics. CA Cancer J Clin. 66(4):271–289.
  • Newman DJ, Cragg GM. 2016. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 79(3):629–661.
  • Tang D, Liu LL, He QR, Yan W, Li D, Gao JM. 2018. Ansamycins with antiproliferative and antineuroinflammatory activity from moss-soil-derived Streptomyces cacaoi subsp. asoensis H2S5. J Nat Prod. 81(9):1984–1991.
  • Taraphdar AK, Roy M, Bhattacharya RK. 2001. Natural products as inducers of apoptosis: implication for cancer therapy and prevention. Curr Sci. 80(11):1387–1396.
  • Torre LA, Siegel RL, Ward EM, Jemal A. 2016. Global cancer incidence and mortality rates and trends − an update. Cancer Epidemiol Biomarkers Prev. 25(1):16–27.
  • Tsiang Y, Li YP. 1977. Flora of China. Beijing: Science Press; p. 25–27.
  • Xu YN, Ling SQ, Zeng DQ, Tang WW. 2018. Antifungal activities and active ingredients of Melodinus suaveolens Champ. ex Benth. Nat Prod Res. 32(12):1481–1483.
  • Yu JQ, Sun XW, Wang ZW, Fang L, Wang X. 2019. Alkaloids from Melodinus henryi with anti-inflammatory activity. J Asian Nat Prod Res. 21(8):820–825.
  • Zhang PZ, Zhang YM, Gu J, Zhang GL. 2016a. Two new alkaloids from Melodinus hemsleyanus Diels. Nat Prod Res. 30(2):162–167.
  • Zhang TD, Zhu BK, Lin J, Yang QX, Feng XF, Wang M. 2016b. Two new compounds from Melodinus suaveolens. Nat Prod Res. 30(21):2483–2490.
  • Zhou J, Feng JH, Fang L. 2017. A novel monoterpenoid indole alkaloid with anticancer activity from Melodinus khasianus. Bioorg Med Chem Lett. 27(4):893–896.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.